DCM
SPRY icon

DAFNA Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History

DAFNA Capital Management’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Sell
139,285
-50,780
-27% -$487K 0.25% 57
2025
Q4 		$2.21M Buy
190,065
+49,565
+35% +$482K 0.51% 47
2025
Q3 		$1.41M Buy
+140,500
New +$2.02M 0.35% 53
2025
Q2 		– Sell
-95,290
Closed -$1.2M – 82
2025
Q1 		$1.2M Buy
95,290
+6,500
+7% +$78.2K 0.34% 51
2024
Q4 		$937K Sell
88,790
-59,504
-40% -$833K 0.24% 59
2024
Q3 		$2.15M Sell
148,294
-90,900
-38% -$1.08M 0.51% 45
2024
Q2 		$2.04M Hold
239,194
– – 0.49% 43
2024
Q1 		$2.44M Sell
239,194
-71,975
-23% -$537K 0.56% 41
2023
Q4 		$1.71M Buy
+311,169
New +$1.36M 0.41% 47

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return